Pharmaceuticals, Biotechnology and Life Sciences
-Leadership team enhanced as Company prepares for Phase 3- NEWTOWN, Pa.–(BUSINESS WIRE)–Palladio Biosciences, Inc. (Palladio) http://palladiobio.com/, a privately-owned, clinical stage…
-Leadership team enhanced as Company prepares for Phase 3- NEWTOWN, Pa.–(BUSINESS WIRE)–Palladio Biosciences, Inc. (Palladio) http://palladiobio.com/, a privately-owned, clinical stage…
SAN FRANCISCO–(BUSINESS WIRE)–#OIS2019–Eyevensys a private, clinical-stage biotechnology company developing non-viral gene therapies for ophthalmic diseases, this week presented results from…
SAN FRANCISCO–(BUSINESS WIRE)–#OIS2019–Eyevensys a private, clinical-stage biotechnology company developing non-viral gene therapies for ophthalmic diseases, this week presented results from…
BOULDER, Colo.–(BUSINESS WIRE)–$CLVS–Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the National Institute for Health and Care Excellence (NICE) has…
BOULDER, Colo.–(BUSINESS WIRE)–$CLVS–Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the National Institute for Health and Care Excellence (NICE) has…
CINCINNATI–(BUSINESS WIRE)–Dennis W. King, PhD, PStat, President and CEO of STATKING Clinical Services (SCS), in Cincinnati, OH will participate in…
Successful completion of Phase 2 monotherapy trial paves way for Phase 3 trials in China in early 2020 CAMBRIDGE, Mass.…
WALTHAM, Mass.–(BUSINESS WIRE)–Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and…
WALTHAM, Mass.–(BUSINESS WIRE)–Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and…